These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30345164)

  • 21. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
    Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative Efficacy of Pharmacotherapy for Macular Edema Secondary to Retinal Vein Occlusion: A Network Meta-analysis.
    Gao S; Zhang Y; Li X; Ge G; Duan J; Lei C; Zeng Y; Cai Z; Zhang M
    Front Pharmacol; 2021; 12():752048. PubMed ID: 34955825
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.
    Hoeh AE; Ach T; Schaal KB; Scheuerle AF; Dithmar S
    Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1635-41. PubMed ID: 19633982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Retinal vein occlusion management algorithm. Part 2. Macular edema].
    Budzinskaya MV; Mazurina NK; Egorov AE; Kuroedov AV; Loskutov IA; Plyukhova AA; Razik S; Ryabtseva AA; Simonova SV
    Vestn Oftalmol; 2015; 131(6):57-66. PubMed ID: 26977728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema: Clinical Outcomes in 130 247 Eyes.
    Ciulla TA; Hussain RM; Taraborelli D; Pollack JS; Williams DF
    Ophthalmol Retina; 2022 Sep; 6(9):796-806. PubMed ID: 35381391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of macular edema secondary to central retinal vein occlusion: an evidence-based.
    Aref AA; Scott IU
    Adv Ther; 2011 Jan; 28(1):40-50. PubMed ID: 21153510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
    Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications.
    Papadia M; Misteli M; Jeannin B; Herbort CP
    Int Ophthalmol; 2014 Dec; 34(6):1193-201. PubMed ID: 25245600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of serum metrics in anti- VEGF treatment for macular edema induced by retinal vein occlusion.
    Wang YC; Zhou CQ; Li RR; Cai Y; Wang MM; Yuan LF; He YQ
    BMC Ophthalmol; 2023 Apr; 23(1):173. PubMed ID: 37095450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.
    Scott IU; VanVeldhuisen PC; Oden NL; Ip MS; Blodi BA; Hartnett ME; Cohen G;
    Ophthalmology; 2011 Feb; 118(2):345-52. PubMed ID: 20926135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intravitreal anti-vascular endothelial growth factor treatment on retinal vasculature in retinal vein occlusion as determined by ultra wide-field fluorescein angiography.
    Vance SK; Chang LK; Imamura Y; Freund KB
    Retin Cases Brief Rep; 2011; 5(4):343-7. PubMed ID: 25390431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.
    Loukianou E; Brouzas D; Chatzistefanou K; Koutsandrea C
    Int Ophthalmol; 2016 Feb; 36(1):21-36. PubMed ID: 25820576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial.
    Song S; Yu X; Zhang P; Gu X; Dai H
    BMC Ophthalmol; 2020 Jun; 20(1):241. PubMed ID: 32560639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Retinal vein occlusion : Intravitreal pharmacotherapies and treatment strategies for the management of macular edema].
    Hattenbach LO; Chronopoulos A; Feltgen N
    Ophthalmologie; 2022 Nov; 119(11):1100-1110. PubMed ID: 36239802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular Edema.
    Iftikhar M; Mir TA; Hafiz G; Zimmer-Galler I; Scott AW; Solomon SD; Sodhi A; Wenick AS; Meyerle C; Jiramongkolchai K; Liu TYA; Arevalo JF; Singh M; Kherani S; Handa JT; Campochiaro PA
    Am J Ophthalmol; 2019 Sep; 205():17-26. PubMed ID: 30954469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions.
    Ivanovska Adjievska B; Boskurt S; Orovcanec N; Dimovska-Jordanova V
    Clin Ophthalmol; 2017; 11():1183-1190. PubMed ID: 28790803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of anti-VEGF results between non-ischemic branch retinal vein occlusion and ischemic branch retinal vein occlusion with early sector panretinal photocoagulation.
    Akdemir SC; Gunay BO
    J Fr Ophtalmol; 2022 Nov; 45(9):1042-1047. PubMed ID: 36127168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.